196 related articles for article (PubMed ID: 24479866)
1. Type II diabetes and impaired glucose tolerance due to severe hyperinsulinism in patients with 1p36 deletion syndrome and a Prader-Willi-like phenotype.
Stagi S; Lapi E; Pantaleo M; Chiarelli F; Seminara S; de Martino M
BMC Med Genet; 2014 Jan; 15():16. PubMed ID: 24479866
[TBL] [Abstract][Full Text] [Related]
2. Prader-Willi-like phenotype: investigation of 1p36 deletion in 41 patients with delayed psychomotor development, hypotonia, obesity and/or hyperphagia, learning disabilities and behavioral problems.
D'Angelo CS; Da Paz JA; Kim CA; Bertola DR; Castro CI; Varela MC; Koiffmann CP
Eur J Med Genet; 2006; 49(6):451-60. PubMed ID: 16564757
[TBL] [Abstract][Full Text] [Related]
3. 1p36 deletion syndrome associated with Prader-Willi-like phenotype.
Tsuyusaki Y; Yoshihashi H; Furuya N; Adachi M; Osaka H; Yamamoto K; Kurosawa K
Pediatr Int; 2010 Aug; 52(4):547-50. PubMed ID: 20113418
[TBL] [Abstract][Full Text] [Related]
4. Lack of evidence for monosomy 1p36 in patients with Prader-Willi-like phenotype.
Rodríguez VR; Mazzucato LF; Pina-Neto JM
Braz J Med Biol Res; 2008 Aug; 41(8):681-3. PubMed ID: 18797701
[TBL] [Abstract][Full Text] [Related]
5. Growth patterns of patients with 1p36 deletion syndrome.
Sangu N; Shimojima K; Shimada S; Ando T; Yamamoto T
Congenit Anom (Kyoto); 2014 May; 54(2):82-6. PubMed ID: 24750553
[TBL] [Abstract][Full Text] [Related]
6. Are Angelman and Prader-Willi syndromes more similar than we thought? Food-related behavior problems in Angelman, Cornelia de Lange, fragile X, Prader-Willi and 1p36 deletion syndromes.
Welham A; Lau J; Moss J; Cullen J; Higgs S; Warren G; Wilde L; Marr A; Cook F; Oliver C
Am J Med Genet A; 2015 Mar; 167A(3):572-8. PubMed ID: 25691410
[TBL] [Abstract][Full Text] [Related]
7. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.
Crinò A; Grugni G
Curr Diab Rep; 2020 Feb; 20(2):7. PubMed ID: 32030506
[TBL] [Abstract][Full Text] [Related]
8. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
Zipf WB
Acta Paediatr Suppl; 1999 Dec; 88(433):115-7. PubMed ID: 10626560
[TBL] [Abstract][Full Text] [Related]
9. Non-insulin dependent diabetes mellitus in a prepubertal child with Prader-Willi syndrome.
Sills IN; Rapaport R
J Pediatr Endocrinol Metab; 1998; 11(2):281-2. PubMed ID: 9642645
[TBL] [Abstract][Full Text] [Related]
10. Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report.
Sani E; Prato GD; Zenti MG; Bordugo A; Trombetta M; Bonora E
Endocr Metab Immune Disord Drug Targets; 2022; 22(10):1053-1057. PubMed ID: 35538810
[TBL] [Abstract][Full Text] [Related]
11. Monosomy 1p36 - a multifaceted and still enigmatic syndrome: four clinically diverse cases with shared white matter abnormalities.
Õiglane-Shlik E; Puusepp S; Talvik I; Vaher U; Rein R; Tammur P; Reimand T; Teek R; Žilina O; Tomberg T; Õunap K
Eur J Paediatr Neurol; 2014 May; 18(3):338-46. PubMed ID: 24529875
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome in adult patients with Prader-Willi syndrome.
Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
[TBL] [Abstract][Full Text] [Related]
13. Atypical Prader-Willi and 15q13.3 Microdeletion Syndromes in a Patient with an Unbalanced Translocation.
Colovati MES; Grossi BM; Nunes GD; Fock RA; Guedes DR; Melaragno MI; Cernach MCSP
Cytogenet Genome Res; 2019; 158(4):192-198. PubMed ID: 31394532
[TBL] [Abstract][Full Text] [Related]
14. Severe lysosomal storage disease of liver in del(1)(p36): a new presentation.
Haimi M; Iancu TC; Shaffer LG; Lerner A
Eur J Med Genet; 2011; 54(3):209-13. PubMed ID: 21145995
[TBL] [Abstract][Full Text] [Related]
15. Pure distal monosomy 10q26 in a patient displaying clinical features of Prader-Willi syndrome during infancy and distinct behavioural phenotype in adolescence.
Lukusa T; Fryns JP
Genet Couns; 2000; 11(2):119-26. PubMed ID: 10893663
[TBL] [Abstract][Full Text] [Related]
16. Somatropin therapy in adults with Prader-Willi syndrome.
Höybye C; Thorén M
Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
[TBL] [Abstract][Full Text] [Related]
17. Mosaicism for deletion 1p36.33 in a patient with obesity and hyperphagia.
Eugster EA; Berry SA; Hirsch B
Am J Med Genet; 1997 Jun; 70(4):409-12. PubMed ID: 9182783
[TBL] [Abstract][Full Text] [Related]
18. Do patients with Prader-Willi syndrome have favorable glucose metabolism?
Qian Y; Xia F; Zuo Y; Zhong M; Yang L; Jiang Y; Zou C
Orphanet J Rare Dis; 2022 May; 17(1):187. PubMed ID: 35525976
[TBL] [Abstract][Full Text] [Related]
19. Detailed phenotype-genotype study in five patients with chromosome 6q16 deletion: narrowing the critical region for Prader-Willi-like phenotype.
Bonaglia MC; Ciccone R; Gimelli G; Gimelli S; Marelli S; Verheij J; Giorda R; Grasso R; Borgatti R; Pagone F; Rodrìguez L; Martinez-Frias ML; van Ravenswaaij C; Zuffardi O
Eur J Hum Genet; 2008 Dec; 16(12):1443-9. PubMed ID: 18648397
[TBL] [Abstract][Full Text] [Related]
20. Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report.
Candler T; McGregor D; Narayan K; Moudiotis C; Burren CP
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):951-955. PubMed ID: 32447330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
